12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Ethicor Pharma, RXi Pharmaceuticals sales and marketing update

RXi granted Ethicor distribution rights to RXI-109 in the EU, with the possibility to extend to other regions, excluding North America, prior to and until the registration of the product in the countries covered by the deal. Under the...

Read the full 184 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >